2022 Q3 Form 10-K Financial Statement

#000162828022024271 Filed on September 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q4 2021
Revenue $24.28M $26.25M $114.1M
YoY Change -10.24% 136.47% 326.32%
Cost Of Revenue $24.94M $27.69M $90.85M
YoY Change 10.74% 176.91% 267.82%
Gross Profit -$659.0K -$1.443M $23.23M
YoY Change -114.55% -244.3% 1029.22%
Gross Profit Margin -2.71% -5.5% 20.36%
Selling, General & Admin $37.71M $31.89M $72.83M
YoY Change 30.59% 90.96% 124.78%
% of Gross Profit 313.52%
Research & Development $849.0K $331.0K $760.0K
YoY Change 361.41% 10.33% -53.52%
% of Gross Profit 3.27%
Depreciation & Amortization $600.0K $1.673M $500.0K
YoY Change 374.97% -54.29% 400.0%
% of Gross Profit 2.15%
Operating Expenses $41.21M $33.89M $282.8M
YoY Change -26.49% 63.74% 217.96%
Operating Profit -$41.87M -$35.34M -$259.6M
YoY Change -18.76% 79.38% 198.76%
Interest Expense $456.0K $234.0K $2.139M
YoY Change 318.35% -101.26% -86.61%
% of Operating Profit
Other Income/Expense, Net $2.574M $572.0K $1.261M
YoY Change 32075.0% 90.67% -80.9%
Pretax Income -$38.82M -$183.7M -$257.0M
YoY Change -24.05% 215.09% 142.34%
Income Tax -$400.0K -$2.119M -$11.79M
% Of Pretax Income
Net Earnings -$37.41M -$191.5M -$256.0M
YoY Change -26.42% 273.99% 160.17%
Net Earnings / Revenue -154.11% -729.52% -224.41%
Basic Earnings Per Share -$0.08 -$0.57
Diluted Earnings Per Share -$0.08 -$388.9K -$0.57
COMMON SHARES
Basic Shares Outstanding 491.8M shares 497.7M shares 447.8M shares
Diluted Shares Outstanding 494.1M shares 447.8M shares

Balance Sheet

Concept 2022 Q3 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.20M $269.9M $269.9M
YoY Change -92.01% 62.82% 62.76%
Cash & Equivalents $25.20M $269.9M $269.9M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $5.673M $4.500M $24.51M
YoY Change 250.83% 20.77% 288.97%
Inventory $29.53M $6.159M $6.159M
Prepaid Expenses $15.08M $20.02M
Receivables $6.000M $3.338M $6.110M
Other Receivables $84.80M $55.87M $55.87M
Total Short-Term Assets $170.0M $362.5M $362.5M
YoY Change -52.28% 101.66% 101.62%
LONG-TERM ASSETS
Property, Plant & Equipment $10.17M $2.905M $15.73M
YoY Change 525.08% 780.3% 7.02%
Goodwill $68.71M $16.16M
YoY Change -38.35% 1287.21%
Intangibles $78.65M $42.55M
YoY Change 5.92% 43.23%
Long-Term Investments $15.82M $28.09M $35.59M
YoY Change -36.79% 642.48% 313.81%
Other Assets $1.235M $903.0K $903.0K
YoY Change -84.43% -87.92% 80.6%
Total Long-Term Assets $200.3M $110.9M $110.9M
YoY Change -16.4% 102.97% 103.17%
TOTAL ASSETS
Total Short-Term Assets $170.0M $362.5M $362.5M
Total Long-Term Assets $200.3M $110.9M $110.9M
Total Assets $370.3M $473.4M $473.4M
YoY Change -37.85% 101.97% 101.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.78M $6.674M $6.674M
YoY Change 228.13% 31.98% 30.86%
Accrued Expenses $11.79M $12.04M $12.04M
YoY Change 51.3% 447.41% 447.41%
Deferred Revenue $3.540M $5.392M
YoY Change -20.7% 377.59%
Short-Term Debt $2.424M $312.0K $312.0K
YoY Change 481.29% -48.0% -48.0%
Long-Term Debt Due $9.598M $58.12M $57.81M
YoY Change
Total Short-Term Liabilities $61.96M $91.12M $91.12M
YoY Change 38.73% 597.63% 595.55%
LONG-TERM LIABILITIES
Long-Term Debt $1.559M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $770.0K $620.0K $10.62M
YoY Change -90.01% -91.48% -45.83%
Total Long-Term Liabilities $2.329M $620.0K $10.62M
YoY Change -69.79% -91.48% -45.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $61.96M $91.12M $91.12M
Total Long-Term Liabilities $2.329M $620.0K $10.62M
Total Liabilities $86.42M $106.8M $109.1M
YoY Change 39.36% 227.2% 134.22%
SHAREHOLDERS EQUITY
Retained Earnings -$709.5M -$605.8M
YoY Change 72.44% 74.64%
Common Stock $517.0K $497.0K
YoY Change 7.04% 44.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $262.8M $363.0M $364.3M
YoY Change
Total Liabilities & Shareholders Equity $370.3M $473.4M $473.4M
YoY Change -37.85% 101.97% 101.98%

Cashflow Statement

Concept 2022 Q3 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$37.41M -$191.5M -$256.0M
YoY Change -26.42% 273.99% 160.17%
Depreciation, Depletion And Amortization $600.0K $1.673M $500.0K
YoY Change 374.97% -54.29% 400.0%
Cash From Operating Activities -$26.92M -$33.29M -$75.53M
YoY Change -15.54% 70.29% 82.14%
INVESTING ACTIVITIES
Capital Expenditures -$3.727M -$4.904M $2.807M
YoY Change 268.28% 3402.86% 1369.63%
Acquisitions
YoY Change
Other Investing Activities -$10.80M -$23.40M -$213.6M
YoY Change -77.46% 715.26% 6352.27%
Cash From Investing Activities -$14.53M -$28.30M -$220.1M
YoY Change -70.31% 840.27% 6188.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $145.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.37M 74.00M $399.3M
YoY Change -68.2% -54.41% 91.92%
NET CHANGE
Cash From Operating Activities -26.92M -33.29M -$75.53M
Cash From Investing Activities -14.53M -28.30M -$220.1M
Cash From Financing Activities -18.37M 74.00M $399.3M
Net Change In Cash -59.82M 12.41M $104.1M
YoY Change -56.83% -91.12% -36.19%
FREE CASH FLOW
Cash From Operating Activities -$26.92M -$33.29M -$75.53M
Capital Expenditures -$3.727M -$4.904M $2.807M
Free Cash Flow -$23.19M -$28.39M -$78.34M
YoY Change -24.84% 46.25% 88.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000837852
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-35561
CY2021 dei Entity Registrant Name
EntityRegistrantName
IDEANOMICS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1778374
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1441 Broadway
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 5116
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
CY2021 dei City Area Code
CityAreaCode
212
CY2021 dei Local Phone Number
LocalPhoneNumber
206-1216
CY2021 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
CY2021 dei Trading Symbol
TradingSymbol
IDEX
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Auditor Firm
AuditorFirmId
606
CY2021 dei Auditor Name
AuditorName
Grassi & Co., CPAs, P.C.
CY2021 dei Auditor Location
AuditorLocation
Jericho, NY
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1200000000 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
491849892 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269863000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
165764000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3338000 usd
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7400000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2772000 usd
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2021Q4 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
266000 usd
CY2020Q4 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
240000 usd
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
54907000 usd
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 usd
CY2021Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
697000 usd
CY2020Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
0 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6159000 usd
CY2020Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20015000 usd
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2629000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4490000 usd
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3726000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
362507000 usd
CY2020Q4 us-gaap Assets Current
AssetsCurrent
179759000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2905000 usd
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
330000 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
0 usd
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
7250000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42546000 usd
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29705000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
16161000 usd
CY2020Q4 us-gaap Goodwill
Goodwill
705000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12827000 usd
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
155000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
35588000 usd
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
8487000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
903000 usd
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7478000 usd
CY2021Q4 us-gaap Assets
Assets
473437000 usd
CY2020Q4 us-gaap Assets
Assets
233869000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6674000 usd
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5057000 usd
CY2021Q4 idex Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
3163000 usd
CY2020Q4 idex Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
31000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5392000 usd
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1129000 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8957000 usd
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1750000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1102000 usd
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
882000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7137000 usd
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2235000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3086000 usd
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
115000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
648000 usd
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1325000 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
312000 usd
CY2020Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
568000 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
57809000 usd
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91117000 usd
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13061000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9647000 usd
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
350000 usd
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
7635000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5073000 usd
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5045000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
620000 usd
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7275000 usd
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
0 usd
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
4653000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
106807000 usd
CY2020Q4 us-gaap Liabilities
Liabilities
37688000 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
7000000 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
365368000 usd
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7000000 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
7000000 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7000000 shares
CY2021Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
3500000000 usd
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
3500000000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
1262000 usd
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
1262000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 usd
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
7485000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
497272525 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
497272525 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
344861295 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
344861295 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
497000 usd
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
345000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
968066000 usd
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
531866000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-605758000 usd
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-349747000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
222000 usd
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1231000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
363027000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
183695000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
2341000 usd
CY2020Q4 us-gaap Minority Interest
MinorityInterest
3739000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187434000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
473437000 usd
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
233869000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114080000 usd
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26759000 usd
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44566000 usd
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
90852000 usd
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
24702000 usd
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1458000 usd
CY2021 us-gaap Gross Profit
GrossProfit
23228000 usd
CY2020 us-gaap Gross Profit
GrossProfit
2057000 usd
CY2019 us-gaap Gross Profit
GrossProfit
43108000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72825000 usd
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32399000 usd
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24862000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
760000 usd
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1635000 usd
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
34710000 usd
CY2020 us-gaap Professional Fees
ProfessionalFees
12541000 usd
CY2019 us-gaap Professional Fees
ProfessionalFees
5828000 usd
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
71070000 usd
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
33230000 usd
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
73669000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
101470000 usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18089000 usd
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
9600000 usd
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
5503000 usd
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5094000 usd
CY2021 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
5432000 usd
CY2020 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2019 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6118000 usd
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5310000 usd
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2229000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
282785000 usd
CY2020 us-gaap Operating Expenses
OperatingExpenses
97701000 usd
CY2019 us-gaap Operating Expenses
OperatingExpenses
111682000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-259557000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-95644000 usd
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-68574000 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1502000 usd
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
108000 usd
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
68000 usd
CY2021 us-gaap Interest Expense
InterestExpense
2139000 usd
CY2020 us-gaap Interest Expense
InterestExpense
16078000 usd
CY2019 us-gaap Interest Expense
InterestExpense
5684000 usd
CY2021 idex Interest Expense Conversion Of Notes
InterestExpenseConversionOfNotes
0 usd
CY2020 idex Interest Expense Conversion Of Notes
InterestExpenseConversionOfNotes
2266000 usd
CY2019 idex Interest Expense Conversion Of Notes
InterestExpenseConversionOfNotes
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
300000 usd
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
8891000 usd
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3940000 usd
CY2021 us-gaap Gain Or Loss On Sale Of Previously Unissued Stock By Subsidiary
GainOrLossOnSaleOfPreviouslyUnissuedStockBySubsidiary
-1264000 usd
CY2020 us-gaap Gain Or Loss On Sale Of Previously Unissued Stock By Subsidiary
GainOrLossOnSaleOfPreviouslyUnissuedStockBySubsidiary
276000 usd
CY2019 us-gaap Gain Or Loss On Sale Of Previously Unissued Stock By Subsidiary
GainOrLossOnSaleOfPreviouslyUnissuedStockBySubsidiary
-952000 usd
CY2021 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
2915000 usd
CY2020 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0 usd
CY2019 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
-3179000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1261000 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6604000 usd
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-433000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-256982000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-98109000 usd
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82694000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11786000 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3308000 usd
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
417000 usd
CY2021 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-11529000 usd
CY2020 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-16780000 usd
CY2019 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-13718000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-256725000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-111581000 usd
CY2019 us-gaap Profit Loss
ProfitLoss
-96829000 usd
CY2021 idex Deemed Dividend Related To Warrant Repricing
DeemedDividendRelatedToWarrantRepricing
0 usd
CY2020 idex Deemed Dividend Related To Warrant Repricing
DeemedDividendRelatedToWarrantRepricing
184000 usd
CY2019 idex Deemed Dividend Related To Warrant Repricing
DeemedDividendRelatedToWarrantRepricing
827000 usd
CY2021 idex Net Income Loss Available To Common Stockholders Basic Including Portion Attributable To Noncontrolling Interest
NetIncomeLossAvailableToCommonStockholdersBasicIncludingPortionAttributableToNoncontrollingInterest
-256725000 usd
CY2020 idex Net Income Loss Available To Common Stockholders Basic Including Portion Attributable To Noncontrolling Interest
NetIncomeLossAvailableToCommonStockholdersBasicIncludingPortionAttributableToNoncontrollingInterest
-111765000 usd
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
58100000 usd
CY2019 idex Net Income Loss Available To Common Stockholders Basic Including Portion Attributable To Noncontrolling Interest
NetIncomeLossAvailableToCommonStockholdersBasicIncludingPortionAttributableToNoncontrollingInterest
-97656000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-714000 usd
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10501000 usd
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
852000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-256011000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-101264000 usd
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-98508000 usd
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
447829204 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
447829204 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213490535 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213490535 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119766859 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119766859 shares
CY2021 us-gaap Profit Loss
ProfitLoss
-256725000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-111581000 usd
CY2019 us-gaap Profit Loss
ProfitLoss
-96829000 usd
CY2019 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2020 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1385000 usd
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3158000 usd
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
407000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-258110000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-108423000 usd
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-96422000 usd
CY2021 idex Deemed Dividend Related To Warrant Repricing
DeemedDividendRelatedToWarrantRepricing
0 usd
CY2020 idex Deemed Dividend Related To Warrant Repricing
DeemedDividendRelatedToWarrantRepricing
184000 usd
CY2019 idex Deemed Dividend Related To Warrant Repricing
DeemedDividendRelatedToWarrantRepricing
827000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2020000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9238000 usd
CY2019 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
844000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-256090000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-99369000 usd
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-98093000 usd
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
43212000 usd
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9113000 usd
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
77819000 usd
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
23005000 usd
CY2019 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2406000 usd
CY2019 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
321000 usd
CY2019 idex Stock Issued During Period Value Debt Settlement
StockIssuedDuringPeriodValueDebtSettlement
110000 usd
CY2019 idex Profit Loss Including Portion Attributable To Noncontrolling Interest
ProfitLossIncludingPortionAttributableToNoncontrollingInterest
-97656000 usd
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58737000 usd
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11972000 usd
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1642000 usd
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
45666000 usd
CY2020 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
8192000 usd
CY2020 idex Noncontrolling Interest Measurement Period Adjustment
NoncontrollingInterestMeasurementPeriodAdjustment
-11584000 usd
CY2020 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
100000 usd
CY2020 idex Stock Issued During Period Value Debt Settlement
StockIssuedDuringPeriodValueDebtSettlement
2314000 usd
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1726000 usd
CY2020 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
12000000 usd
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
182498000 usd
CY2020 idex Profit Loss Including Portion Attributable To Noncontrolling Interest
ProfitLossIncludingPortionAttributableToNoncontrollingInterest
-112202000 usd
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3158000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187434000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21982000 usd
CY2021 idex Adjustments To Additional Paid In Capital Contingent Share Amount
AdjustmentsToAdditionalPaidInCapitalContingentShareAmount
1520000 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
59808000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2318000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8290000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
157766000 usd
CY2021 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
157000 usd
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3878000 usd
CY2021 idex Profit Loss Including Portion Attributable To Noncontrolling Interest
ProfitLossIncludingPortionAttributableToNoncontrollingInterest
-257190000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1385000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
365368000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-256725000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-111581000 usd
CY2019 us-gaap Profit Loss
ProfitLoss
-96829000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
21982000 usd
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
11972000 usd
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9113000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6118000 usd
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5310000 usd
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2229000 usd
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
856000 usd
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1556000 usd
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2019 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
873000 usd
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-14785000 usd
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5511000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
362000 usd
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1219000 usd
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2021 idex Bad Debt Expense
BadDebtExpense
0 usd
CY2020 idex Bad Debt Expense
BadDebtExpense
1643000 usd
CY2019 idex Bad Debt Expense
BadDebtExpense
0 usd
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-12011000 usd
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3308000 usd
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 usd
CY2021 idex Issuance Of Common Stock And Warrants For Professional Fees
IssuanceOfCommonStockAndWarrantsForProfessionalFees
1430000 usd
CY2020 idex Issuance Of Common Stock And Warrants For Professional Fees
IssuanceOfCommonStockAndWarrantsForProfessionalFees
0 usd
CY2019 idex Issuance Of Common Stock And Warrants For Professional Fees
IssuanceOfCommonStockAndWarrantsForProfessionalFees
0 usd
CY2021 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 usd
CY2020 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
2266000 usd
CY2019 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 usd
CY2021 idex Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
1198000 usd
CY2020 idex Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
0 usd
CY2019 idex Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
0 usd
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-9600000 usd
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5503000 usd
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5094000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
300000 usd
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
8891000 usd
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3940000 usd
CY2021 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-11529000 usd
CY2020 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-16780000 usd
CY2019 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-13718000 usd
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2020 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
5926000 usd
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
172540000 usd
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
51319000 usd
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
73669000 usd
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-1323000 usd
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
276000 usd
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-952000 usd
CY2021 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
2915000 usd
CY2020 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0 usd
CY2019 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
-3179000 usd
CY2021 idex Digital Tokens Received As Payment For Services
DigitalTokensReceivedAsPaymentForServices
0 usd
CY2020 idex Digital Tokens Received As Payment For Services
DigitalTokensReceivedAsPaymentForServices
0 usd
CY2019 idex Digital Tokens Received As Payment For Services
DigitalTokensReceivedAsPaymentForServices
40700000 usd
CY2021 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
CY2020 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
CY2019 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-245000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5941000 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6214000 usd
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2278000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4418000 usd
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13089000 usd
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6745000 usd
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2881000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1577000 usd
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2206000 usd
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2862000 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2188000 usd
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
652000 usd
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
168000 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
665000 usd
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1269000 usd
CY2019 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-1256000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
686000 usd
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2445000 usd
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3718000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75530000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41468000 usd
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13784000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2807000 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
191000 usd
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1816000 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3712000 usd
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2021 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
2495000 usd
CY2020 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2019 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
645000 usd
CY2021 idex Payments To Acquire Interest In Subsidiaries
PaymentsToAcquireInterestInSubsidiaries
100859000 usd
CY2020 idex Payments To Acquire Interest In Subsidiaries
PaymentsToAcquireInterestInSubsidiaries
0 usd
CY2019 idex Payments To Acquire Interest In Subsidiaries
PaymentsToAcquireInterestInSubsidiaries
623000 usd
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
70047000 usd
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2021 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
44941000 usd
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2850000 usd
CY2019 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 usd
CY2021 idex Payments For Advances To Third Parties
PaymentsForAdvancesToThirdParties
0 usd
CY2020 idex Payments For Advances To Third Parties
PaymentsForAdvancesToThirdParties
1988000 usd
CY2019 idex Payments For Advances To Third Parties
PaymentsForAdvancesToThirdParties
0 usd
CY2021 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
691000 usd
CY2020 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0 usd
CY2019 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0 usd
CY2021 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
473000 usd
CY2020 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
1529000 usd
CY2019 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-220089000 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3500000 usd
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1794000 usd
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
295000000 usd
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
27000000 usd
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
9132000 usd
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
80000000 usd
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
12000000 usd
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
196835000 usd
CY2020 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
191440000 usd
CY2019 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2821000 usd
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
157000 usd
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
7148000 usd
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2021 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
8820000 usd
CY2020 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 usd
CY2019 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 usd
CY2019 idex Proceeds From Repayments Of Borrowings From To Third Parties
ProceedsFromRepaymentsOfBorrowingsFromToThirdParties
0 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3877000 usd
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-2999000 usd
CY2019 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
3161000 usd
CY2021 idex Proceeds From Repayments Of Borrowings From To Third Parties
ProceedsFromRepaymentsOfBorrowingsFromToThirdParties
0 usd
CY2020 idex Proceeds From Repayments Of Borrowings From To Third Parties
ProceedsFromRepaymentsOfBorrowingsFromToThirdParties
-2540000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
399295000 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
208049000 usd
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15114000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
423000 usd
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50000 usd
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
104099000 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
163131000 usd
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-473000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165764000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2633000 usd
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3106000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269863000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165764000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2633000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1410000 usd
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1516000 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3004000 usd
CY2019 us-gaap Interest Paid Net
InterestPaidNet
73000 usd
CY2021 us-gaap Stock Issued1
StockIssued1
0 usd
CY2020 us-gaap Stock Issued1
StockIssued1
8192000 usd
CY2019 us-gaap Stock Issued1
StockIssued1
0 usd
CY2021 idex Stock Issued During Period Value Acquisitions Of Convertible Note Conversion
StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion
157766000 usd
CY2020 idex Stock Issued During Period Value Acquisitions Of Convertible Note Conversion
StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion
45114000 usd
CY2019 idex Stock Issued During Period Value Acquisitions Of Convertible Note Conversion
StockIssuedDuringPeriodValueAcquisitionsOfConvertibleNoteConversion
0 usd
CY2021 idex Purchase Price Adjustment In Acquisitions
PurchasePriceAdjustmentInAcquisitions
0 usd
CY2020 idex Purchase Price Adjustment In Acquisitions
PurchasePriceAdjustmentInAcquisitions
12848000 usd
CY2019 idex Purchase Price Adjustment In Acquisitions
PurchasePriceAdjustmentInAcquisitions
0 usd
CY2021 idex Disposal Assets In Exchange Of Gtb
DisposalAssetsInExchangeOfGtb
0 usd
CY2020 idex Disposal Assets In Exchange Of Gtb
DisposalAssetsInExchangeOfGtb
0 usd
CY2019 idex Disposal Assets In Exchange Of Gtb
DisposalAssetsInExchangeOfGtb
20219000 usd
CY2021 idex Stock Issued During Period Value Acquisition Of Intangible Assets
StockIssuedDuringPeriodValueAcquisitionOfIntangibleAssets
0 usd
CY2020 idex Stock Issued During Period Value Acquisition Of Intangible Assets
StockIssuedDuringPeriodValueAcquisitionOfIntangibleAssets
0 usd
CY2019 idex Stock Issued During Period Value Acquisition Of Intangible Assets
StockIssuedDuringPeriodValueAcquisitionOfIntangibleAssets
10005000 usd
CY2021 idex Stock Issued During Period Value Acquisition Of Long Term Investments
StockIssuedDuringPeriodValueAcquisitionOfLongTermInvestments
59808000 usd
CY2020 idex Stock Issued During Period Value Acquisition Of Long Term Investments
StockIssuedDuringPeriodValueAcquisitionOfLongTermInvestments
0 usd
CY2019 idex Stock Issued During Period Value Acquisition Of Long Term Investments
StockIssuedDuringPeriodValueAcquisitionOfLongTermInvestments
40715000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3100000 usd
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021 idex Number Of Business Units
NumberOfBusinessUnits
2 businessunit
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269900000 usd
CY2021Q4 idex Number Of Subsidiaries Requiring Capital Liquidity Requirements
NumberOfSubsidiariesRequiringCapitalLiquidityRequirements
2 subsidiary
CY2021Q4 idex Capital Liquidity Requirements From Subsidiaries
CapitalLiquidityRequirementsFromSubsidiaries
2200000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
15600000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7100000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
600000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-256700000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-605800000 usd
CY2021 idex Number Of Additional Businesses Acquired
NumberOfAdditionalBusinessesAcquired
2 business
CY2020Q4 us-gaap Goodwill
Goodwill
705000 usd
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
155000 usd
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
8487000 usd
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7478000 usd
CY2020Q4 us-gaap Assets
Assets
233869000 usd
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2235000 usd
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
115000 usd
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19000 usd
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5045000 usd
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7275000 usd
CY2020Q4 us-gaap Liabilities
Liabilities
37688000 usd
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-349747000 usd
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1231000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
183695000 usd
CY2020Q4 us-gaap Minority Interest
MinorityInterest
3739000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187434000 usd
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
233869000 usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18089000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-95644000 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3308000 usd
CY2020 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-16780000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-111581000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-101264000 usd
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2020 us-gaap Profit Loss
ProfitLoss
-111581000 usd
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3158000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-108423000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9238000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-99369000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-111581000 usd
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3308000 usd
CY2020 idex Income Loss From Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-16780000 usd
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
51319000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41468000 usd
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, the Company evaluates its estimates, including those related to the bad debt allowance, collectability of notes receivable, sales returns, fair values of financial instruments, equity investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, asset retirement obligations, income taxes, and contingent liabilities, among others. The Company bases its estimates on assumptions, both historical and forward looking, that are believed to be reasonable, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities.</span></div>
CY2019 idex Impairment Losses Right Of Use Assets
ImpairmentLossesRightOfUseAssets
0 usd
CY2021 us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
2 note
CY2021Q4 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
0 usd
CY2020Q4 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
2000000 usd
CY2020 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
200000 usd
CY2019Q4 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
1500000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
101500000 usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18100000 usd
CY2019 idex Digital Currency Amount Received
DigitalCurrencyAmountReceived
61100000 usd
CY2019Q4 us-gaap Share Price
SharePrice
0.23
CY2020Q4 us-gaap Inventory Net
InventoryNet
0 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
245000 usd
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
90000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5824000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6159000 usd
CY2020 idex Impairment Losses Right Of Use Assets
ImpairmentLossesRightOfUseAssets
6300000 usd
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2021 idex Inventory Valuation Reserves Increase
InventoryValuationReservesIncrease
856000 usd
CY2021 idex Inventory Valuation Reserves Decrease
InventoryValuationReservesDecrease
0 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
856000 usd
CY2021 us-gaap Impairment Of Investments
ImpairmentOfInvestments
1500000 usd
CY2020 us-gaap Impairment Of Investments
ImpairmentOfInvestments
200000 usd
CY2019 us-gaap Impairment Of Investments
ImpairmentOfInvestments
3000000 usd
CY2021 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
7900000 usd
CY2020 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
16700000 usd
CY2019 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
13100000 usd
CY2021 idex Impairment Losses Right Of Use Assets
ImpairmentLossesRightOfUseAssets
100000 usd
CY2021Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
500000 usd
CY2021Q4 idex Escrow Held In Trust
EscrowHeldInTrust
21400000 usd
CY2021Q4 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
-200000 usd
CY2020Q4 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
100000 usd
CY2019Q4 us-gaap Translation Adjustment Functional To Reporting Currency Net Of Tax
TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax
-100000 usd
CY2020Q4 idex Escrow Held In Trust
EscrowHeldInTrust
0 usd
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2300000 usd
CY2019 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
24394 usd
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
7 businessunit
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114080000 usd
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26759000 usd
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44566000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114080000 usd
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26759000 usd
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44566000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114080000 usd
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26759000 usd
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44566000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3338000 usd
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7400000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5392000 usd
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1129000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2772000 usd
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 usd
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 usd
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
600000 usd
CY2021 idex Contract With Customer Asset Revenue Expected To Be Recognized
ContractWithCustomerAssetRevenueExpectedToBeRecognized
600000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLossCurrent
15000000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent
833000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000 usd
CY2021Q4 idex Debt Securities Available For Sale Impairment Loss
DebtSecuritiesAvailableForSaleImpairmentLoss
15817000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3800000 usd
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
117617000 usd
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
114588000 usd
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-257281000 usd
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-94097000 usd
CY2021 us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
-0.57
CY2021 us-gaap Basic Earnings Per Share Pro Forma
BasicEarningsPerShareProForma
-0.57
CY2020 us-gaap Diluted Earnings Per Share Pro Forma
DilutedEarningsPerShareProForma
-0.40
CY2020 us-gaap Basic Earnings Per Share Pro Forma
BasicEarningsPerShareProForma
-0.40
CY2021 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
447829204 shares
CY2021 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
447829204 shares
CY2020 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
232707448 shares
CY2020 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
232707448 shares
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
700000 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4945000 usd
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8619000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1607000 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1219000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3338000 usd
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7400000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5500000 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1219000 usd
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
350000 usd
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1219000 usd
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2021 idex Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
-38000 usd
CY2020 idex Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
0 usd
CY2019 idex Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1607000 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1219000 usd
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5200000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3738000 usd
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
790000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
833000 usd
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
460000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2905000 usd
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
330000 usd
CY2021 us-gaap Depreciation
Depreciation
500000 usd
CY2020 us-gaap Depreciation
Depreciation
100000 usd
CY2019 us-gaap Depreciation
Depreciation
100000 usd
CY2018Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
8000000 usd
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4653000 usd
CY2021 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0 usd
CY2021 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
0 usd
CY2021 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
0 usd
CY2021 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-4653000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
0 usd
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
5094000 usd
CY2020 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0 usd
CY2020 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
441000 usd
CY2020 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
0 usd
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4653000 usd
CY2018Q4 us-gaap Goodwill
Goodwill
705000 usd
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
30949000 usd
CY2019Q4 us-gaap Goodwill
Goodwill
31654000 usd
CY2020 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-12848000 usd
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-12000 usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
18089000 usd
CY2020Q4 us-gaap Goodwill
Goodwill
705000 usd
CY2021 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
186000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
101470000 usd
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
117445000 usd
CY2021 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1000 usd
CY2021 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
704000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
16161000 usd
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5600000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
98775000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6142000 usd
CY2021Q4 idex Finite Lived Intangible Assets Impairment Loss
FiniteLivedIntangibleAssetsImpairmentLoss
50618000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42015000 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31378000 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1726000 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29652000 usd
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
99306000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6142000 usd
CY2021Q4 idex Finite Lived Intangible Assets Impairment Loss
FiniteLivedIntangibleAssetsImpairmentLoss
50618000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
42546000 usd
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
31431000 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1726000 usd
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29705000 usd
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
13900000 usd
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
20500000 usd
CY2019 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
66800000 usd
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4199000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4183000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3918000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3454000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3404000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
22857000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42015000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
7500000 usd
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
4787000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
28088000 usd
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3700000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
35588000 usd
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
8487000 usd
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3700000 usd
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
38070000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3665000 usd
CY2021 idex Equity Method Investment Reclassification To Subsidiaries
EquityMethodInvestmentReclassificationToSubsidiaries
2372000 usd
CY2021 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
7864000 usd
CY2021 idex Equity Method Investment Reclassification To Equity Method Investee
EquityMethodInvestmentReclassificationToEquityMethodInvestee
250000 usd
CY2021 idex Equity Method Investment Realized Gain Loss On Disposal Due To Investee Share Issuance
EquityMethodInvestmentRealizedGainLossOnDisposalDueToInvesteeShareIssuance
-31000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
28088000 usd
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17881000 usd
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2600000 usd
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-131000 usd
CY2020 idex Equity Method Investment Reclassification To Subsidiaries
EquityMethodInvestmentReclassificationToSubsidiaries
0 usd
CY2020 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
16650000 usd
CY2020 idex Equity Method Investment Reclassification To Equity Method Investee
EquityMethodInvestmentReclassificationToEquityMethodInvestee
0 usd
CY2020 idex Equity Method Investment Realized Gain Loss On Disposal Due To Investee Share Issuance
EquityMethodInvestmentRealizedGainLossOnDisposalDueToInvesteeShareIssuance
0 usd
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3700000 usd
CY2021 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
0 usd
CY2020 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
0 usd
CY2019 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
0 usd
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1300000 usd
CY2021Q1 idex Number Of Seats On Board Of Directors
NumberOfSeatsOnBoardOfDirectors
4 seat
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12800000 usd
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
200000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12700000 usd
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
100000 usd
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1764000 usd
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1600000 usd
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1708000 usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
720000 usd
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
349000 usd
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
317000 usd
CY2021 us-gaap Sublease Income
SubleaseIncome
0 usd
CY2020 us-gaap Sublease Income
SubleaseIncome
74000 usd
CY2019 us-gaap Sublease Income
SubleaseIncome
42000 usd
CY2021 us-gaap Lease Cost
LeaseCost
2484000 usd
CY2020 us-gaap Lease Cost
LeaseCost
1875000 usd
CY2019 us-gaap Lease Cost
LeaseCost
1983000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1856000 usd
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
991000 usd
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1407000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14293000 usd
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
486000 usd
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
935000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3629000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3647000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2728000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2281000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1685000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
222000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14192000 usd
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1459000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12733000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4500000 usd
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3700000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7100000 usd
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2200000 usd
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
57811000 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
58121000 usd
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
565000 usd
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
568000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
58121000 usd
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
568000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2021Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.040
CY2020Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.014
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 idex Aggregate Offering Price
AggregateOfferingPrice
150000000 usd
CY2021Q1 idex Common Stock Share Price Calculated As Percentage Of Market Price
CommonStockSharePriceCalculatedAsPercentageOfMarketPrice
0.030
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145500000 usd
CY2021 idex Commission And Transaction Fees
CommissionAndTransactionFees
4500000 usd
CY2021Q2 idex Sale Of Stock Purchase Price As Percent Of Market Price Period One
SaleOfStockPurchasePriceAsPercentOfMarketPricePeriodOne
0.95
CY2021Q2 idex Sale Of Stock Purchase Price As Percent Of Market Price Period Two
SaleOfStockPurchasePriceAsPercentOfMarketPricePeriodTwo
0.96
CY2019 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
7400000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21800000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1100000 shares
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22000000 usd
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12000000 usd
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9100000 usd
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14936726 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.13
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15854166 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.60
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2421657 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.78
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2421499 usd
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1682658 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.72
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1599161 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.58
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
25087416 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.29
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M1D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18554241 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9562000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.49
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5589084 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7731175 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2966509 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.69
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4250042 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.10
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21843781 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.74
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y21D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4596393 usd
CY2021Q4 idex Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
14264369 shares
CY2021Q4 idex Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageExercisePrice
1.53
CY2021 idex Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm
P7Y8M15D
CY2021Q4 idex Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue
3927341 usd
CY2021Q4 idex Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber
7579412 shares
CY2021 idex Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageExercisePrice
2.15
CY2021 idex Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
P9Y4M13D
CY2021Q4 idex Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue
669052 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
12900000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7700000 usd
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000 usd
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8400000 usd
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
11800000 usd
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8500000 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.00
CY2021 idex Weighted Average Remaining Life Of Warrants
WeightedAverageRemainingLifeOfWarrants
P0Y7M9D
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1100000 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
900000 shares
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
12400000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-256011000 usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-101264000 usd
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-98508000 usd
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
447829204 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213490535 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119766859 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
447829204 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213490535 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119766859 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
55968000 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28018000 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
55045000 shares
CY2021 idex Income Loss From Continuing Operations Before Income Taxes After Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromContinuingOperationsBeforeIncomeTaxesAfterEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-268511000 usd
CY2020 idex Income Loss From Continuing Operations Before Income Taxes After Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromContinuingOperationsBeforeIncomeTaxesAfterEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-114889000 usd
CY2019 idex Income Loss From Continuing Operations Before Income Taxes After Equity Method Investments And Equity Method Investment Other Than Temporary Impairment
IncomeLossFromContinuingOperationsBeforeIncomeTaxesAfterEquityMethodInvestmentsAndEquityMethodInvestmentOtherThanTemporaryImpairment
-96412000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-371000 usd
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-241000 usd
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-176000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-10134000 usd
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 usd
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 usd
CY2021 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-1506000 usd
CY2020 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-3067000 usd
CY2019 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-514000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
225000 usd
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1107000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11786000 usd
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3308000 usd
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
417000 usd
CY2021 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
4 business
CY2021 idex Deferred Tax Liabilities Business Acquisition
DeferredTaxLiabilitiesBusinessAcquisition
12200000 usd
CY2021 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
4 business
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 idex Effective Income Tax Rate Reconciliation Nondeductible Expense Stock Awards Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockAwardsPercent
-0.006
CY2020 idex Effective Income Tax Rate Reconciliation Nondeductible Expense Stock Awards Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockAwardsPercent
-0.006
CY2019 idex Effective Income Tax Rate Reconciliation Nondeductible Expense Stock Awards Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseStockAwardsPercent
-0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.105
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.037
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2021 idex Effective Income Tax Rate Reconciliation Nondeductible Expense Business Acquisition Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBusinessAcquisitionPercent
-0.007
CY2020 idex Effective Income Tax Rate Reconciliation Nondeductible Expense Business Acquisition Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBusinessAcquisitionPercent
0
CY2019 idex Effective Income Tax Rate Reconciliation Nondeductible Expense Business Acquisition Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseBusinessAcquisitionPercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2021 idex Effective Income Tax Rate Reconciliation Nondeductible Interest Expense Percent
EffectiveIncomeTaxRateReconciliationNondeductibleInterestExpensePercent
-0.002
CY2020 idex Effective Income Tax Rate Reconciliation Nondeductible Interest Expense Percent
EffectiveIncomeTaxRateReconciliationNondeductibleInterestExpensePercent
-0.020
CY2019 idex Effective Income Tax Rate Reconciliation Nondeductible Interest Expense Percent
EffectiveIncomeTaxRateReconciliationNondeductibleInterestExpensePercent
-0.012
CY2021 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
-0.005
CY2020 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.011
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.013
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.103
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.157
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.164
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.050
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.013
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.005
CY2021 idex Effective Income Tax Rate Reconciliation Nondeductible Expense On Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOnContingentConsideration
0.009
CY2020 idex Effective Income Tax Rate Reconciliation Nondeductible Expense On Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOnContingentConsideration
0.011
CY2019 idex Effective Income Tax Rate Reconciliation Nondeductible Expense On Contingent Consideration
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOnContingentConsideration
-0.011
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.044
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
46693000 usd
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
23585000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
6554000 usd
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
5967000 usd
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
873000 usd
CY2020Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
4371000 usd
CY2021Q4 idex Deferred Tax Assets Section1231 Carryforward
DeferredTaxAssetsSection1231Carryforward
2360000 usd
CY2020Q4 idex Deferred Tax Assets Section1231 Carryforward
DeferredTaxAssetsSection1231Carryforward
usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1012000 usd
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
0 usd
CY2021Q4 idex Deferred Tax Assets Nonqualified Options
DeferredTaxAssetsNonqualifiedOptions
2999000 usd
CY2020Q4 idex Deferred Tax Assets Nonqualified Options
DeferredTaxAssetsNonqualifiedOptions
1927000 usd
CY2021Q4 idex Deferred Tax Assets Convertible Notes
DeferredTaxAssetsConvertibleNotes
0 usd
CY2020Q4 idex Deferred Tax Assets Convertible Notes
DeferredTaxAssetsConvertibleNotes
827000 usd
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
563000 usd
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
281000 usd
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
281000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
10728000 usd
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
7996000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
126000 usd
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2021Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
5081000 usd
CY2020Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
3596000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
77270000 usd
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
48550000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74972000 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46732000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
357000 usd
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
81000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
5954000 usd
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6782000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
1060000 usd
CY2020Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
0 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7371000 usd
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6863000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
5073000 usd
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
5045000 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
28200000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
28200000 usd
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
16500000 usd
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14800000 usd
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15468000 usd
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14807000 usd
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30275000 usd
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
16457000 usd
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46732000 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
28240000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74972000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
300000 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2019 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2020 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
256000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
256000 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2020Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
1700000 usd
CY2020 us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
1 vendor
CY2020 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
1300000 usd
CY2020Q4 us-gaap Former Gain Contingency Recognized In Current Period
FormerGainContingencyRecognizedInCurrentPeriod
400000 usd
CY2020Q3 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
5000000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269900000 usd
CY2021Q4 idex Regulatory Licenses Title Insurance Minimum Cash
RegulatoryLicensesTitleInsuranceMinimumCash
2000000 usd
CY2021Q4 idex Regulatory Licenses Broker Dealer Cash
RegulatoryLicensesBrokerDealerCash
200000 usd
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
4700000 usd
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
1300000 usd
CY2021 idex Loss Contingency Credit Monitoring Service Period
LossContingencyCreditMonitoringServicePeriod
P1Y
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1.000
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.040
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1.000
CY2021 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
1.000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
29595000 usd
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
37285000 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
999000 usd
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
899000 usd

Files In Submission

Name View Source Status
0001628280-22-024271-index-headers.html Edgar Link pending
0001628280-22-024271-index.html Edgar Link pending
0001628280-22-024271.txt Edgar Link pending
0001628280-22-024271-xbrl.zip Edgar Link pending
aconsentforoutstandings-8s.htm Edgar Link pending
ex101amendedandrestated201.htm Edgar Link pending
ex21ideanomicsex21546297561.htm Edgar Link pending
ex37seriesbcod.htm Edgar Link pending
ex37seriesbcod001.jpg Edgar Link pending
ex37seriesbcod002.jpg Edgar Link pending
ex37seriesbcod003.jpg Edgar Link pending
ex37seriesbcod004.jpg Edgar Link pending
ex37seriesbcod005.jpg Edgar Link pending
ex37seriesbcod006.jpg Edgar Link pending
ex37seriesbcod007.jpg Edgar Link pending
ex37seriesbcod008.jpg Edgar Link pending
ex41ideanomicsdescriptiono.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ideanomicsconsent12312020b.htm Edgar Link pending
ideanomicsformex991draft54.htm Edgar Link pending
idex-20211231.htm Edgar Link pending
idex-20211231.xsd Edgar Link pending
image_0.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
indx-20211231x10kexx311.htm Edgar Link pending
indx-20211231x10kexx312.htm Edgar Link pending
indx-20211231x10kexx321.htm Edgar Link pending
indx-20211231x10kexx322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
idex-20211231_cal.xml Edgar Link unprocessable
idex-20211231_def.xml Edgar Link unprocessable
idex-20211231_lab.xml Edgar Link unprocessable
idex-20211231_pre.xml Edgar Link unprocessable
idex-20211231_htm.xml Edgar Link completed
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable